ARE

Unpacking Alexandria Real Estate Equities (ARE) for Investors

A strong performer from today's morning trading session is Alexandria Real Estate Equities, whose shares rose 2.2% to $117.6 per share. For those of you thinking about investing in the stock, here is a brief value analysis of the stock using the company's basic fundamental ratios.

a Lower P/B Ratio Than Its Sector Average but Trades Above Its Graham Number:

Alexandria Real Estate Equities, Inc. (NYSE: ARE), an S&P 500® company, is a best-in-class, mission-driven life science REIT making a positive and lasting impact on the world. The company belongs to the Real Estate sector, which has an average price to earnings (P/E) ratio of 31.12 and an average price to book (P/B) ratio of 2.15. In contrast, Alexandria Real Estate Equities has a trailing 12 month P/E ratio of 145.2 and a P/B ratio of 1.11.

When we divide Alexandria Real Estate Equities's P/E ratio by its expected EPS growth rate of the next five years, we obtain its PEG ratio of -6.48. Since it's negative, the company has negative growth expectations, and most investors will probably avoid the stock unless it has an exceptionally low P/E and P/B ratio.

Increasing Revenues but Narrowing Margins:

2018 2019 2020 2021 2022 2023
Revenue (M) $1,327 $1,531 $1,886 $2,114 $2,589 $2,886
Net Margins 28% 24% 41% 27% 20% 4%
Net Income (M) $379 $363 $771 $571 $522 $104
Net Interest Expense (M) $157 $174 $172 $142 $94 $74
Depreciation & Amort. (M) $478 $545 $698 $821 $1,002 $1,093
Diluted Shares (M) 103 113 126 147 162 171
Earnings Per Share $3.52 $3.12 $6.01 $3.82 $3.18 $0.54
EPS Growth n/a -11.36% 92.63% -36.44% -16.75% -83.02%
Avg. Price $107.33 $129.49 $146.61 $176.47 $172.63 $117.6
P/E Ratio 30.41 41.37 24.31 46.08 54.29 217.78
Free Cash Flow (M) -$357 -$541 -$563 -$1,080 -$2,013 -$1,788
CAPEX (M) $927 $1,225 $1,445 $2,090 $3,307 $3,418
Total Debt (M) $5,478 $6,777 $7,563 $8,792 $10,160 $11,316
The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS